SCHEMBL20937191

SCHEMBL20937191

COc1c(C)cnc(CN(C(=O)OC(C)(C)C)c2cccc(-c3ccccc3)c2)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
GABRA1 P14867 1/20 0.38
GABRG2 P18507 1/20 0.38
GABRB3 P28472 1/20 0.38
GABRA5 P31644 1/20 0.38
GABRA3 P34903 1/20 0.38
GABRA2 P47869 1/20 0.38
GABRA6 Q16445 1/20 0.38
KMT2A Q03164 4/20 0.37
WDR5 P61964 3/20 0.37
HSP90AA1 P07900 1/20 0.36
F2 P00734 3/20 0.36
AGXT P21549 1/20 0.36
BRD4 O60885 1/20 0.35
CHRM2 P08172 3/20 0.34
CHRM1 P11229 3/20 0.34
CHRM3 P20309 2/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19512668 0.91 AGXT (0.40) HDAC1HDAC8HDAC6KMT2AWDR5
SCHEMBL30285123 0.91 WDR5 (0.36) HDAC1HDAC8HDAC6GABRA1GABRG2
SCHEMBL19512978 0.91 WDR5 (0.36) HDAC1HDAC8HDAC6GABRA1GABRG2
SCHEMBL19512876 0.90 KMT2A (0.42) HDAC1HDAC8HDAC6KMT2AWDR5
SCHEMBL19512704 0.90 HDAC1 (0.36) HDAC1HDAC8HDAC6GABRA1GABRG2
SCHEMBL19512937 0.90 HDAC1 (0.39) HDAC1HDAC8HDAC6KMT2AWDR5
SCHEMBL19512701 0.89 HDAC1 (0.41) HDAC1HDAC8HDAC6KMT2AWDR5
SCHEMBL20914591 0.89 KMT2A (0.41) HDAC1HDAC8HDAC6KMT2AWDR5
SCHEMBL19513026 0.89 HDAC1 (0.40) HDAC1HDAC8HDAC6KMT2AWDR5
SCHEMBL28997300 0.89 HDAC1 (0.41) HDAC1HDAC8HDAC6KMT2AWDR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109311813-B Palladium-catalyzed meta-C-H functionalized universal ligands 斯克利普斯研究院 2023-02-28 CN disclosed
US-10696635-B2 Versatile ligand for palladium-catalyzed meta-C—H functionalizations of aromatic substrates THE SCRIPPS RESEARCH INSTITUTE (US) 2020-06-30 US disclosed
US-20190119212-A1 A VERSATILE LIGAND FOR PALLADIUM-CATALYZED META-C-H FUNCTIONALIZATIONS THE SCRIPPS RESEARCH INSTITUTE 2019-04-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190119212-A1 A VERSATILE LIGAND FOR PALLADIUM-CATALYZED META-C-H FUNCTIONALIZATIONS AHR, PAH, DOHH HDAC1 1011/4885HDAC8 1139/4885HDAC6 860/4885
US-10696635-B2 Versatile ligand for palladium-catalyzed meta-C—H functionalizations of aromatic substrates PAH, AHR, DDC HDAC1 1111/4885HDAC8 1817/4885HDAC6 1082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.